BioSpace News Archive

Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces the enrollment of the 60th patient in its Phase 2 double blind, placebo controlled clinical trial of AG013.

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc. of the April 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Health Canada is conducting a safety review after issues were discovered during a clinical trial involving rheumatoid arthritis patients being treated with the drug tofacitinib.

Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated.

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that its Chief Executive Officer, Mr. Cameron Reynolds, is scheduled to present at two conferences in the U.S. next week.

Susan G. Komen®, the world’s largest breast cancer nonprofit, has selected RKD Group as their marketing and fundraising engagement partner to support their mission to end breast cancer.

Michael Barr, CEO of Bridgeway Institute, located in Somerset, Kentucky, is proud to announce an alliance between Bridgeway and Rex Chapman, Mr. Kentucky Basketball, to jointly reach out to attack the addiction problem in Kentucky and surrounding states

According to Coherent Market Insights, the Typhoid fever vaccines market was valued at US$ 225.0 million in 2018, and is projected to exhibit a CAGR of 11.9% over the forecast period (2018–2026).

Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company, today announced the pricing of its underwritten registered public offering of 27,272,727 shares of its common stock, offered at a price to the public of $1.10 per share for expected gross proceeds of $30.0 million,

A pilot study from Cincinnati Children’s Hospital Medical Center of 45 middle school kids shows that more than a third of those screened had abnormal levels of blood sugar or high cholesterol